3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
5
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
4
Neoplasms
3
Sarcoma
2
Lymphoma, Follicular
2
Lymphoma
2
Glioblastoma
2
Uveal Melanoma
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Thrombosis
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumor, Adult
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pneumothorax
1
Pituitary Neoplasms
1
Philadelphia Chromosome
1
Pathologic Complete Response
1
Pancreatic Neoplasms
1
Oropharyngeal Neoplasms
1
Opioid-Related Disorders
1
Neoplasms, Plasma Cell
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Metastatic Castration-resistant Prostate Cancer
1
Meningioma
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Lung Neoplasms
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Interventions
Dexamethasone
2
vistusertib
1
ricolinostat
1
pomalidomide
1
irinotecan sucrosofate
1
idelalisib
1
daratumumab
1
bermekimab
1
atezolizumab
1
alovudine
1
TKM-080301
1
TIC10 compound
1
S-Adenosylmethionine
1
Prostatectomy
1
Pluvicto
1
MicroRNAs
1
Magnetic Resonance Spectroscopy
1
Lenalidomide
1
Ipilimumab
1
Ga(III)-DOTATOC
1
Fluorouracil
1
Cyclophosphamide
1
Blood Specimen Collection
1
(225)Ac-PSMA-617
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Disease
×
Blood Specimen Collection
×
Clear all
NCT07054346
2026-04-01
LUTACT
University of California, San Francisco
Phase 1
Recruiting
45 enrolled